BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15501676)

  • 1. Interactions between BRCT repeats and phosphoproteins: tangled up in two.
    Glover JN; Williams RS; Lee MS
    Trends Biochem Sci; 2004 Nov; 29(11):579-85. PubMed ID: 15501676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
    Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
    J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites.
    Xu C; Wu L; Cui G; Botuyan MV; Chen J; Mer G
    J Mol Biol; 2008 Aug; 381(2):361-72. PubMed ID: 18582474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boundaries and physical characterization of a new domain shared between mammalian 53BP1 and yeast Rad9 checkpoint proteins.
    Alpha-Bazin B; Lorphelin A; Nozerand N; Charier G; Marchetti C; Bérenguer F; Couprie J; Gilquin B; Zinn-Justin S; Quéméneur E
    Protein Sci; 2005 Jul; 14(7):1827-39. PubMed ID: 15987907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
    Derbyshire DJ; Basu BP; Serpell LC; Joo WS; Date T; Iwabuchi K; Doherty AJ
    EMBO J; 2002 Jul; 21(14):3863-72. PubMed ID: 12110597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BRCA1 C-terminal domain: structure and function.
    Huyton T; Bates PA; Zhang X; Sternberg MJ; Freemont PS
    Mutat Res; 2000 Aug; 460(3-4):319-32. PubMed ID: 10946236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA; Lowery DM; Nguyen A; Yaffe MB
    Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.
    Liu J; Pan Y; Ma B; Nussinov R
    Structure; 2006 Dec; 14(12):1811-21. PubMed ID: 17161371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the BARD1 BRCT domains.
    Birrane G; Varma AK; Soni A; Ladias JA
    Biochemistry; 2007 Jul; 46(26):7706-12. PubMed ID: 17550235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival.
    Yamane K; Wu X; Chen J
    Mol Cell Biol; 2002 Jan; 22(2):555-66. PubMed ID: 11756551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.
    Laufer M; Nandula SV; Modi AP; Wang S; Jasin M; Murty VV; Ludwig T; Baer R
    J Biol Chem; 2007 Nov; 282(47):34325-33. PubMed ID: 17848578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
    Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
    Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.